Birdshot Chorioretinopathy treated with dexamethasone intravitreal implant and a biologic response modifier: a successful management

• Autor(a) principal: Aragão, Ricardo Evangelista Marrocos de
• Data de Publicação: 2017
• Outros Autores: Barreira, Ieda Maria Alexandre, Muccioli, Cristina, Oliveira Neto, Francisco Holanda, Arrais, Barbara Lorena Alves, Oliveira, Francisco George Magalhães de, Carneiro, Gustavo Jose Arruda Mendes
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da Universidade Federal do Ceará (UFC)
• Texto Completo: http://www.repositorio.ufc.br/handle/riufc/28503
• topic: Vasculite Retiniana; Retinal Vasculitis

Birdshot chorioretinopathy is an organ-specific, potentially blinding chronic of bilateral inflammation of the posterior eye segment. It is seen mainly in persons who have the HLA-A29 haplotype. The diagnosis remains clinical and is based in his hallmark, which is the presence of multiples white dots throughout the fundus, resembling a shotgun pattern. The immune mechanisms involved in its pathogenesis remains unclear and the long-term outcome is guarded. However, the use of immunosuppressive agents and newer therapies demonstrated control of the inflammation and is a hope mainly in refractory cases. We report a case of Birdshot chorioretinopathy treated successfully with steroids and immunosuppressive agents.